Vik Bajaj has long lived at the intersection of physical sciences, engineering, data science, and the life sciences—first as an academic working to improve diagnostic imaging at Stanford University and later as a chief scientific officer at GRAIL and Verily. Now, as a founder and CEO of Foresite Labs, the technologist turned venture capitalist is using his experience to create new companies that are leveraging AI and other technologies to transform healthcare. We spoke to Bajaj about the changing data landscape around healthcare, the potential for technology to improve health outcomes, and what it takes for an entrepreneur to get his attention today.
Using a Digital Cognitive Behavior Therapy to Treat Diabetes and Heart Disease
Disrupting Pain Signals with Precision
A Diagnostics Company Moves to Developing Precision Cancer Therapies
Characterizing the Immunome at Scale
Delivering Oxygen to Tissue in Need
Using Gene Therapy to Create a Drug Biofactory within a Patient
Finding New Uses for TNF Inhibitors
Using AI to Map the Undiscovered World of Bioactive Compounds in Plants
Improving the Delivery of Drugs through Thin Film Freezing
Using CRISPR to Target RNA Instead of DNA
An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Conditions
Managing Neurodegenerative Diseases with Better Data to Improve Outcomes
A Small Molecule Cancer Drug That Promotes an Adaptive Immune Response
Sloan-Kettering Spin-Out Harnesses AI to Diagnose Cancer
Bringing Innovation to Cell and Gene Therapy Manufacturing
Tapping Psychedelics for their Anti-Inflammatory Powers
Advancing Cell Therapies Beyond Cancer
How the Pandemic Transformed a Small Diagnostics Company
Eliminating Security, Privacy, and Regulatory Burdens with Synthetic Data
Using Computational Discovery to Build Better Immunotherapies
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology